{"DataElement":{"publicId":"7533650","version":"1","preferredName":"Cancer Outcome Fear of Cancer Recurrence Questionnaire Assessment Text","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The result of an action._A 7-item self-report measure of a patient's fear of cancer recurrence. It enables a cancer survivor to assess the emotional distress caused by concern that their cancer will return or progress after anti-cancer treatment._a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"Mali_Outc_Fear_ASSESS_TXT","context":"PhenX","contextVersion":"1","DataElementConcept":{"publicId":"7533648","version":"1","preferredName":"Malignant Neoplasm Outcome Fear of Cancer Recurrence Questionnaire","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas._The result of an action._A 7-item self-report measure of a patient's fear of cancer recurrence. It enables a cancer survivor to assess the emotional distress caused by concern that their cancer will return or progress after anti-cancer treatment.","longName":"Mali_Outc_Fear","context":"PhenX","contextVersion":"1","ObjectClass":{"publicId":"7533641","version":"1","preferredName":"Malignant Neoplasm Outcome","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:The result of an action.","longName":"C9305:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6972473-2687-3DD5-E053-4EBD850A3CFD","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"ONEDATA","dateModified":"2020-12-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7544280","version":"1","preferredName":"Fear of Cancer Recurrence Questionnaire","preferredDefinition":"A 7-item self-report measure of a patient's fear of cancer recurrence. It enables a cancer survivor to assess the emotional distress caused by concern that their cancer will return or progress after anti-cancer treatment.","longName":"C176830","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fear of Cancer Recurrence Questionnaire","conceptCode":"C176830","definition":"A 7-item self-report measure of a patient's fear of cancer recurrence. It enables a cancer survivor to assess the emotional distress caused by concern that their cancer will return or progress after anti-cancer treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B8066DC0-286A-37D5-E053-4EBD850ADEF4","latestVersionIndicator":"Yes","beginDate":"2021-01-03","endDate":null,"createdBy":"PANH","dateCreated":"2021-01-03","modifiedBy":"ONEDATA","dateModified":"2021-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B6AAB34E-79DF-70DE-E053-4EBD850AF4B3","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"PANH","dateModified":"2021-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018321","version":"1","preferredName":"Assessment Text","preferredDefinition":"a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"ASSESS_TXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184342","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"Text","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2103-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2BC789C-301C-4477-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-26","endDate":null,"createdBy":"PWEST","dateCreated":"2002-12-26","modifiedBy":"CAMPBELB","dateModified":"2008-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2793652","version":"1","longName":"PhenX","context":"PhenX","ClassificationSchemeItems":[{"publicId":"6641384","version":"1","longName":"Cancer Outcomes & Survivorship","context":"PhenX"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element Cancer Outcome Fear of Cancer Recurrence Questionnaire Assessment Text does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Cancer Outcome Fear of Cancer Recurrence Questionnaire Assessment Text does not have Preferred Question Text","url":null,"context":"PhenX"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B695048D-32FD-4230-E053-4EBD850A09A3","latestVersionIndicator":"Yes","beginDate":"2020-12-17","endDate":null,"createdBy":"PANH","dateCreated":"2020-12-17","modifiedBy":"PANH","dateModified":"2021-02-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}